FMR1 and fragile X syndrome: 3’dTP-PCR and MCA was used for FXS screening because of its inherent advantage of being a single-step, closed-tube, homogeneous assay for rapid and large-scale screening for FMR1 repeat expansion mutations in males and females, with high sensitivity from unmodified genomic DNA.